1. insights
  2. strategy catalyst
  3. care delivery
  4. cencora acquires majority stake in oneoncology doubling down on specialty
Strategist | strategy-catalyst

Cencora acquires majority stake in OneOncology, doubling down on specialty drug synergies

Visual banner featuring the text "The Strategist" and a graphic evoking a football play diagram.
Related Topics:
Care DeliveryPayer StrategyFinance and Operations
Relevant Roles:
Chief Strategy Officers

Cencora (formerly AmerisourceBergen) is expanding its stake in specialty practice network OneOncology, building on an initial investment from 2023 in partnership with the PE firm TPG. The distributor is acquiring TPG’s remaining equity in a $5B debt-financed transaction that values the oncology chain at $7.4B and wipes $1.3B of corporate debt off its books.

If your organization is a member, you already have access.

Log in using your organizational email

Interested in membership?

Contact us to start your journey today